PL2473172T3 - Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca - Google Patents

Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca

Info

Publication number
PL2473172T3
PL2473172T3 PL10814383T PL10814383T PL2473172T3 PL 2473172 T3 PL2473172 T3 PL 2473172T3 PL 10814383 T PL10814383 T PL 10814383T PL 10814383 T PL10814383 T PL 10814383T PL 2473172 T3 PL2473172 T3 PL 2473172T3
Authority
PL
Poland
Prior art keywords
methods
heart failure
treating heart
bisphosphonate compositions
bisphosphonate
Prior art date
Application number
PL10814383T
Other languages
English (en)
Inventor
Kenneth W Lyles
Cathleen S Colon-Emeric
Christopher M O'connor
Richard S Stack
Colleen Stack-D'niaye
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of PL2473172T3 publication Critical patent/PL2473172T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10814383T 2009-09-01 2010-09-01 Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca PL2473172T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23879709P 2009-09-01 2009-09-01
EP10814383.5A EP2473172B1 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure
PCT/US2010/047417 WO2011028737A2 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure

Publications (1)

Publication Number Publication Date
PL2473172T3 true PL2473172T3 (pl) 2015-08-31

Family

ID=43649931

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10814383T PL2473172T3 (pl) 2009-09-01 2010-09-01 Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca

Country Status (12)

Country Link
US (2) US9867838B2 (pl)
EP (1) EP2473172B1 (pl)
CN (2) CN105920023A (pl)
DK (1) DK2473172T3 (pl)
ES (1) ES2537216T3 (pl)
HR (1) HRP20150496T1 (pl)
HU (1) HUE025737T2 (pl)
PL (1) PL2473172T3 (pl)
PT (1) PT2473172E (pl)
SI (1) SI2473172T1 (pl)
SM (1) SMT201500124B (pl)
WO (1) WO2011028737A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
CA2856030A1 (en) * 2011-11-16 2013-05-23 Duke University Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US20230149430A1 (en) * 2020-04-06 2023-05-18 Duke University Compositions and methods for the treatment of infection-induced cardiomyopathy

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE3428524A1 (de) 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
EP0243173B1 (en) 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE10199052I1 (de) 1986-11-21 2002-01-10 Novartis Ag Neue substituierte Alkandiphosphonsaeuren
US5057505A (en) 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
GB8808138D0 (en) 1988-04-07 1988-05-11 Leo Pharm Prod Ltd Chemical compounds
ES2072015T3 (es) * 1990-08-21 1995-07-01 Upjohn Co Derivados del acido bisfosfonico como agente anti-artritico.
US5157027A (en) 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
HUT66379A (en) 1991-05-28 1994-11-28 Procter & Gamble Calcium, trace mineral, vitamin d and drug therapy combinations
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6117856A (en) 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
DE19738005A1 (de) * 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
JP2002501757A (ja) 1998-01-29 2002-01-22 メルク エンド カムパニー インコーポレーテッド ストレス応答性キナーゼのモジュレーターの特定方法
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
WO2001049295A1 (en) 2000-01-04 2001-07-12 The Regents Of The University Of California Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification
WO2001064207A2 (en) * 2000-03-01 2001-09-07 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
US8052987B2 (en) 2000-06-20 2011-11-08 Novartis Pharmaceuticals Corporation Method of administering bisphosphonates
US20040157799A1 (en) * 2001-05-02 2004-08-12 Seaman John J Pharmaceutical uses of bisphosphonates
US20030064965A1 (en) 2001-10-02 2003-04-03 Jacob Richter Method of delivering drugs to a tissue using drug-coated medical devices
AU2003226148A1 (en) 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20060205692A1 (en) 2002-05-11 2006-09-14 Montes Imber F 1,1-and 1,2-Bisphosphonates as apoliprotein e modulators
US20050026871A1 (en) 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
CA2497353C (en) 2002-09-16 2012-08-28 Novartis Ag Method for preventing or reducing secondary fractures after hip fracture
BR0315383A (pt) 2002-10-15 2005-08-23 Novartis Ag Biofosfofatos para o tratamento de aterosclerose e dispositivos compreendendo os mesmos
JP5269281B2 (ja) * 2002-12-30 2013-08-21 セルジーン コーポレイション フルオロアルコキシ置換１，３−ジヒドロイソインドリル化合物およびそれらの医薬としての使用
US10517883B2 (en) * 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
JP4621202B2 (ja) 2003-06-27 2011-01-26 バイオレスト リミテッド 急性冠症候群を治療する方法
US20060051407A1 (en) 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
KR20060058134A (ko) 2003-09-19 2006-05-29 화이자 프로덕츠 인코포레이티드 2-알킬리덴-19-노르-비타민 디 유도체 및비스포스포네이트의 조합을 포함하는 약학 조성물 및 방법
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
WO2006019843A1 (en) 2004-07-15 2006-02-23 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US20060069068A1 (en) 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by pathological calcification
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
WO2007117706A2 (en) * 2006-04-07 2007-10-18 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
EP1925621A1 (en) * 2006-11-27 2008-05-28 Novartis AG Crystalline forms of zoledronic acid
US20080146489A1 (en) 2006-12-15 2008-06-19 Pacetti Stephen D Regional delivery of therapeutic agents for the treatment of vascular diseases
WO2008116133A1 (en) 2007-03-21 2008-09-25 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
JP5539221B2 (ja) * 2007-12-21 2014-07-02 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）およびその使用
CN101259133A (zh) * 2008-03-28 2008-09-10 王洪 唑来磷酸用于制备预防及治疗骨质疏松症的药物
WO2009148709A1 (en) 2008-04-16 2009-12-10 University Of Utah Research Foundation Pharmacological targeting of vascular malformations

Also Published As

Publication number Publication date
ES2537216T3 (es) 2015-06-03
EP2473172A4 (en) 2013-01-16
EP2473172B1 (en) 2015-04-08
WO2011028737A2 (en) 2011-03-10
DK2473172T3 (en) 2015-06-15
WO2011028737A3 (en) 2011-07-14
PT2473172E (pt) 2015-06-25
SI2473172T1 (sl) 2015-07-31
EP2473172A2 (en) 2012-07-11
US20180125869A1 (en) 2018-05-10
CN102639137A (zh) 2012-08-15
CN105920023A (zh) 2016-09-07
SMT201500124B (it) 2015-07-09
US20120208786A1 (en) 2012-08-16
US9867838B2 (en) 2018-01-16
WO2011028737A8 (en) 2012-05-18
HUE025737T2 (en) 2016-05-30
HRP20150496T1 (hr) 2015-08-14

Similar Documents

Publication Publication Date Title
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
IL215975A (en) Heart failure device
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL239918A0 (en) Preparations for the treatment of colitis
IL212348A0 (en) Treatment method
ZA201106165B (en) Compositions and methods for preventing cardiac arrhythmia
EP2575669A4 (en) SUPPORTED DENTAL IMPLANT TREATMENT
IL215932A0 (en) Compositions and methods for treating burns
GB0802116D0 (en) Treatment
PL2391391T3 (pl) Sposób sterylizacji
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2575855A4 (en) METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
EP2459206A4 (en) METHODS OF TREATMENT USING THYMUS-BASED COMPOSITIONS
EP2486890A4 (en) SUPPORT FOR AN IMPLANT
IL217492A0 (en) Treatment method
IL219565A0 (en) Method for treating heart failure with stresscopin-like peptides
SG10201408508YA (en) Combination composition useful for treating cardiovascular diseases
SI2473172T1 (sl) Bisfosfonat sestavki in postopki za zdravljenje srčne okvare
EP2485853A4 (en) TREATMENT OF FLOORS
GB0811992D0 (en) Treatment
GB0900599D0 (en) Treatment
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
GB0913968D0 (en) Treatment
GB0806047D0 (en) Treatment of heart failure
PL2263454T3 (pl) Kompozycja uzdatniająca